It's an interesting bio.
The nearest competitor, NA1 (NoNo) is currently on Phase 3 trial (expected to completed December 2020).
But AGN's is still pre-clinical.
It takes NoNo 8 years from Phase 1 to Phase 3.
I think it's a long way to go.
ARGENICA THERAPEUTICS LIMITED IPO Analysis, page-2
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
74.0¢ |
Change
-0.010(1.33%) |
Mkt cap ! $90.88M | |||
| Open | High | Low | Value | Volume |
| 74.5¢ | 75.0¢ | 73.0¢ | $55.07K | 74.05K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 35000 | 73.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 74.0¢ | 7975 | 2 |
View Market Depth
| Last trade - 13.09pm 04/06/2024 (20 minute delay) ? |
|
|||||
|
Last
73.0¢ |
Change
-0.010 ( 2.01 %) |
||||
| Open | High | Low | Volume | ||
| 75.0¢ | 75.5¢ | 73.0¢ | 35164 | ||
| Last updated 12.06pm 04/06/2024 ? | |||||
| AGN (ASX) Chart |